AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04729049 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Patient controlled analgesia with intravenous morphine
Description: Patient-controlled intermittent boluses of morphine 1 mg (maximum once every 15 minutes).
Study NCT04729049 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Patient controlled analgesia with intravenous morphine
Description: Patient-controlled intermittent boluses of morphine 1 mg (maximum once every 15 minutes).
Study NCT06062576 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Yunnan Baiyao
Description: On the basis of the optimal clinical treatment scheme, Yunnan Baiyao powder or ointment was used to treat the wound for 2 weeks
Study NCT06499948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment with Dapagliflozin followed by Spironolactone followed by their combination
Description: After titrating the renin-angiotensin-system inhibitor dose, patients will receive 10 mg of Dapagliflozin once daily for 4 weeks. Dapagliflozin will be stopped after 4 weeks. The first treatment period will be followed by 4 weeks of wash-out. After the first wash-out period, treatment with Spironolactone will be started. Patients will receive 25 mg of Spironolactone once daily for 4 weeks. Spironolactone will be stopped after 4 weeks. The second treatment period will be followed by 4 weeks of wash-out. After the second wash-out period, treatment with both Spironolactone and Dapagliflozin will be started. Patients will receive 25 mg of Spironolactone once daily in combination with 10 mg of Dapagliflozin daily for a duration of 4 weeks. Spironolactone and Dapagliflozin will be stopped after 4 weeks. The third treatment period will be followed by 4 weeks of wash-out, after which the study will be finalized.
Study NCT06549049 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TranS-C for PTSD
Description: The Transdiagnostic sleep and circadian intervention (TranS-C), developed by Allison Harvey, Ph.D. and Daniel Buysse, M.D., involves a patient-centered, module-based, flexibly structured approach that tackles numerous sleep disturbances using evidence-based strategies with the goal of improving sleep and related impairments in daytime functioning. It is thus well-suited for tackling sleep disturbances and the associated impairments in social, occupational and overall functioning in veterans with PTSD. The proposed study is a randomized, controlled clinical trial examining the effectiveness of a modified TranS-C intervention for veterans with PTSD. The modified approach, TranS-C for PTSD (TSC-PTSD), elevates the importance of nightmare-focused, apnea-focused, and insomnia-focused modules relative to the standard intervention, incorporates an evidence-based relaxation module, and modifies the nightmare and apnea modules based on strategies used for veterans in the VA healthcare system.
Study NCT06549049 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sleep Psychoeducation Control
Description: Participants will receive psychoeducation about sleep.
Study NCT04275310 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Microeconomic Intervention
Description: The intervention will consist of six sessions on six different days. Sessions will be held at VCU or at one of VCU's community partners. Each session will last for around 2 ½ hours (around 15 hours total). There will be breaks and food will be provided. During the sessions the facilitators will provide education on a variety of topics, including economic services that are available to people living in Richmond, job skills (such as creating a resume and dealing with discrimination at work), personal finance education, gender transition ideas, and HIV prevention. The sessions will occur in a group of about 4-10 transgender women.
Study NCT04838912 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cool Kids (Chilled) Anxiety program adapted to children and youths with autism and anxiety disorders.
Description: CBT program for anxiety in teenagers with autism
Study NCT06439914 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [89Zr]Zr-DFO-emapalumab
Description: Radiotracer \[89Zr\]Zr-DFO-emapalumab administration followed by 3 PET Scans (day 0, day 1 and day 3-5) within 14 days of starting immunotherapy and repeated once 25-45 days after immunotherapy started
Study NCT05282706 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lavender Oil
Description: A hydrogel lavender oil infused aromatherapy patch
Study NCT05282706 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mandarin Oil
Description: A hydrogel mandarin oil infused aromatherapy patch
Study NCT05282706 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peppermint oil
Description: A hydrogel peppermint oil infused aromatherapy patch
Study NCT05282706 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A placebo patch containing no aromatherapy oil
Study NCT06128941 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Repeated sprint
Description: * Duration of the study: 8 weeks of participation.~* Each repeated sprint training protocol: 2 training sessions per week for 4 weeks.~* Collection sessions: 3 collection sessions will be carried out: before the start of the training protocol - T0; at the end of the protocol, in week 4 - T1; and late, 4 weeks after the end of the protocol, in week 8 - T2.~* Training sessions: will be carried out on an ergometer and will consist of 3 sets of 5 sprints of 10s all-out with 20s of rest between sprints, and 5 minutes of rest between sets.
Study NCT06128941 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Repeated sprint
Description: * Duration of the study: 8 weeks of participation.~* Each repeated sprint training protocol: 2 training sessions per week for 4 weeks.~* Collection sessions: 3 collection sessions will be carried out: before the start of the training protocol - T0; at the end of the protocol, in week 4 - T1; and late, 4 weeks after the end of the protocol, in week 8 - T2.~* Training sessions: will be carried out on an ergometer and will consist of 3 sets of 5 sprints of 10s all-out with 20s of rest between sprints, and 5 minutes of rest between sets.
Study NCT06214520 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App-based Motivational Interviewing & Human health coaching
Description: Patients in the intervention arm will be given a smartwatch wearable device and will be encouraged to wear it for at least 10 hours per day. Patient's daily activities such as number of steps taken, sedentary time, heart rate, sleep time and exercise will be captured and synced to the EMPOWER+ app for real-time tracking.~App-based Motivational Interviewing \& Human health coaching:~The health coach will conduct 1:1 or group-based health coaching as appropriate virtually over the EMPOWER+ app, videoconferencing platform or telephone call.
Study NCT04914416 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Verum T13
Description: Verum T13 is a polyphenol mix extract ( olive leaf, pomelo, pomegranate, and/or blackcurrant extract) with white kidney bean extract. Daily dosage is 1000 mg in 3 capsules.
Study NCT04914416 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Verum T13
Description: Verum T13 is a polyphenol mix extract ( olive leaf, pomelo, pomegranate, and/or blackcurrant extract) with white kidney bean extract. Daily dosage is 1000 mg in 3 capsules.
Study NCT04914416 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Verum T14
Description: Verum T14 is a polyphenol mix extract ( olive leaf, pomelo, pomegranate, and/or blackcurrant extract) with white kidney bean extract. Daily dosage is 900 mg in 3 capsules.
Study NCT04914416 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Verum T14
Description: Verum T14 is a polyphenol mix extract ( olive leaf, pomelo, pomegranate, and/or blackcurrant extract) with white kidney bean extract. Daily dosage is 900 mg in 3 capsules.
Study NCT04914416 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Verum T15
Description: Verum T15 is a polyphenol mix extract ( olive leaf, pomelo, pomegranate, and/or blackcurrant extract) with white kidney bean extract, Zinc, and, black currant leaf extracts. Daily dosage is 1000 mg in 3 capsules.
Study NCT04914416 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Verum T15
Description: Verum T15 is a polyphenol mix extract ( olive leaf, pomelo, pomegranate, and/or blackcurrant extract) with white kidney bean extract, Zinc, and, black currant leaf extracts. Daily dosage is 1000 mg in 3 capsules.
Study NCT06214520 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Empower+ App & Smartwatch wearable tracker
Description: Patients in the intervention arm will be given a smartwatch wearable device and will be encouraged to wear it for at least 10 hours per day. Patient's daily activities such as number of steps taken, sedentary time, heart rate, sleep time and exercise will be captured and synced to the EMPOWER+ app for real-time tracking.
Study NCT06214520 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Empower+ App & Smartwatch wearable tracker
Description: Patients in the intervention arm will be given a smartwatch wearable device and will be encouraged to wear it for at least 10 hours per day. Patient's daily activities such as number of steps taken, sedentary time, heart rate, sleep time and exercise will be captured and synced to the EMPOWER+ app for real-time tracking.
Study NCT05138094 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally invasive simultaneous resection
Description: One minimally invasive surgical procedure wherein both the primary colorectal carcinoma and the liver metastases are removed.
Study NCT05138094 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Minimally invasive two-stage resection
Description: Two minimally invasive surgical procedures wherein the primary colorectal carcinoma and the liver metastases are removed
Study NCT04653064 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Placebo Cream
Description: Approximately 1 teaspoon of exfoliating skin scrub delivered approximately 5 minutes prior to pain tasks will coincide with verbal descriptors of the cream as being analgesic.
Study NCT05323149 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Giving saline (loading dose of 1gm of saline 0.9%, followed by a 1gm of maintenance saline dose over 8 hours for 48 h).
Study NCT05323149 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: Giving TXA (loading dose of 1gm of TXA, followed by a 1gm of maintenance dose over 8 hours for 48 h).
Study NCT06627556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H021
Description: H021 oral tablet.
Study NCT06627556 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: H021 Placebo
Description: H021 placebo oral tablet.
Study NCT04653064 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control Cream
Description: Approximately 1 teaspoon of exfoliating skin scrub delivered approximately 5 minutes prior to pain tasks will coincide with verbal descriptors of the cream as one of no effect.
Study NCT04914416 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Verum T16
Description: Verum T16 is a polyphenol mix extract ( olive leaf, pomelo, pomegranate, and/or blackcurrant extract) with white kidney bean extract, and Zinc. Daily dosage is 1000 mg in 3 capsules.
Study NCT04914416 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Verum T16
Description: Verum T16 is a polyphenol mix extract ( olive leaf, pomelo, pomegranate, and/or blackcurrant extract) with white kidney bean extract, and Zinc. Daily dosage is 1000 mg in 3 capsules.
Study NCT06450470 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Therapeutic lens alone
Description: Therapeutic lens will be apposed on the patient's eye after crosslinking. Therapeutic lens will be maintained without interruption until the first postoperative visit (Day 2) when it will be removed by the investigator.
Study NCT06450470 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Therapeutic lens + amniotic membrane (Visio-AMTRIX)
Description: Amniotic membrane (Visio-AMTRIX) will be apposed under therapeutic lens on the patient's eye after crosslinking. Amniotic membrane and therapeutic lens will be maintained without interruption until the first postoperative visit (Day 2) when it will be removed by the investigator.
Study NCT05966194 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RRx-001
Description: RRx-001 for injection (4 mg or 8 mg)
Study NCT05966194 — intervention group
Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Intensity Modulated Radiation Therapy (IMRT)
Description: Intensity Modulated Radiation Therapy of up to 72 Gy
Study NCT05966194 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy (IMRT)
Description: Intensity Modulated Radiation Therapy of up to 72 Gy
Study NCT05966194 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cisplatin for injection 100 mg/m2
Description: Cisplatin for injection 100 mg/m2
Study NCT05966194 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin for injection 100 mg/m2
Description: Cisplatin for injection 100 mg/m2
Study NCT05855551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Base cash transfer
Description: Program beneficiaries will receive a monthly transfer of 800 BDT. A government-to-person (G2P) payment system will be used, which will transfer cash on a monthly basis. Under this new system, beneficiaries will select one of the following payment channels based on convenience: mobile financial services or through a bank transfer (which women in remote areas could access through agent banking). Each month, women will receive a text message from the government informing her that the money has been credited to her account.
Study NCT05855551 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavior change communication (BCC)
Description: The BCC strategy has two different components:~* Monthly courtyard meetings: Courtyard sessions (12 to 15 women) will be organized at a place no more than 15 to 20 minutes walking distance from the beneficiary's home. Family members (husband, mother-in-law, ...) are invited to join the meeting. Sessions are part of a continuous 4-session cycle. Each session will lasts 1.5 hours and will use different didactic methods. Topics include pregnancy nutrition and care, breastfeeding, importance of different micronutrients, and nutrition and care during lactation. The importance of a healthy diet during pregnancy is repeated in each session. Pregnant women receive a take-home poster that summarizes how to eat a healthy diet during pregnancy.~* Home visits: Visits will cover the content of any sessions missed by pregnant women and will reinforce the messages regarding maternal diet on the take-home poster.
Study NCT05855551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food basket
Description: The monthly food basket will provide 10 kg micronutrient fortified rice , 3.5 kg of lentils, and 1000 ml of oil, valued at 800 BDT . Assuming a the ration is split equally among the 5 members of an average-sized household in rural Bangladesh and using food composition data for Bangladesh, the food basket is estimated to provide 354 kcal and 11 g of protein per person per day. The food basket will be provided once every month.~The individually packaged foods will be distributed at the Union parishad office, community clinic, or another government facility in the first week of each month. The UDW will inform the beneficiaries of the place and time of the food distribution. Recipients will only receive the food when they present their food card. The card will also be used to record receipt of each ration. If beneficiaries cannot attend the food distribution themselves, a designated nominee can pick up the ration on their behalf.
Study NCT05855551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Top-up cash
Description: The monthly top-up cash of 1,000 BDT will be added to the base amount that is part of the standard program. For the top-up cash transfer, a person-to-person payment system is used. WFP will contract with one popular mobile banking service (either bKash or Rockets) for the monthly top-up cash transfers. About two weeks after receiving the base cash transfer, women will receive the top-up cash through a mobile account (which can also be used to receive the base cash transfer). A text message will be sent to the beneficiary to inform her that the top-up transfer has been made into her account.
Study NCT04630886 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid injection
Description: subcutaneous injection of 50mg/ml TXA
Study NCT04630886 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine Epinephrine
Description: subcutaneous injection of 1% lidocaine mixed with 1:200,000 epinephrine
Study NCT04630886 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Epinephrine
Description: subcutaneous injection of 1% lidocaine mixed with 1:200,000 epinephrine
Study NCT04165486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ION464
Description: ION464 will be administered by IT injection.
Study NCT04165486 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: ION464-matching placebo will be administered by IT injection.
Study NCT06426888 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental interventional group 1(scapular stabilization exercise therapy)
Description: Ball stabilization exercise: While standing close to the wall, the participant will be asked to position her affected hand on the ball and keep the ball from moving as disturbance will be applied in different directions.~Wall push up: While facing wall patient will be asked to place both hands on wall, shoulder width apart. He will be instruct to breath in, bend his elbows, lean into wall and hold this position for one second then breath out slowly push back until arms are straight again Wall slides~• Patient will be asked to lean his head, upper thorax and butts against the wall, place his hands and arms against the wall in high five position.
Study NCT06426888 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental :interventional group II (scapular mobilizations)
Description: Patient lies on unaffected side close to the edge of the treatment bench with hips and knees bent for stability.~Therapist will start by supporting the patient arm on his/her forearm so that shoulder is in maximally loose pack position.~Then he/she will grab on the scapula with both hands. One hand supports the scapula from cranial around the acromion and scapular spine and other hand from the caudal at the inferior angle of scapula.~Then both hands move the scapula cranially over the thorax into elevation and caudally into the depression, upward/downward rotation as well as retraction and protraction.
Study NCT05896124 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2mg CS0159
Description: Oral QD
Study NCT05896124 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral QD
Study NCT04570423 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eflapegrastim
Description: Eflapegrastim supplied in prefilled, single-use syringes for SC injection.
Study NCT06304272 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Irrigating Traumatic Wound with Drinking Water
Description: Irrigating Traumatic Wound with Drinking Water and Normal Saline
Study NCT04570423 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Chemotherapy agents may include doxorubicin, ifosfamide, docetaxel, CHOP regimen, etoposide, cyclophosphamide and vincristine which will be administered as per standard of care per the Primary Care physician's treatment plan.
Study NCT06019819 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: strengthening exercise
Description: Perform general physical training activities conducted in schools including upper limb forward elevation, lateral elevation, touching toes in standing and cervical range of motion, strengthening exercise will be performed for 3days a week for 4 weeks.
Study NCT06019819 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Postural correction exercises
Description: Chin Tuck, Strengthening shoulder retractors, Stretching sternocleidomastoiD, Pectorals stretch For strengthening exercises 3 sets of 10 repetitions were performed with 6 seconds rest period between each set and a hold of 6 seconds. Stretching exercises will be performed in 3 sets of 10 repetitions ,30 seconds hold and 30 seconds rest period between each exercise. The exercises were performed 3days a week for 4 weeks.
Study NCT05292183 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrical Stimulation
Description: We will use a computer randomized stimulation of specific areas in the amygdala while showing a computer randomized set of pictures.
Study NCT06027892 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Two-fraction stereotactic radiotherapy
Description: Definitive prostate radiotherapy will be delivered to a dose biologically comparable to 40 Gy in 5 treatments, but in only 2 treatments
Study NCT06027892 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Five-fraction stereotactic radiotherapy
Description: Definitive prostate radiotherapy will be delivered to a standard stereotactic dose of 40 Gy in 5 treatments
Study NCT04949451 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey protein supplement
Description: Participants consume whey protein at the beginning of the eating period.
Study NCT04949451 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketogenic aid
Description: Participants consume ketogenic aid upon waking.
Study NCT04949451 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control group - time restricted feeding only
Description: Time restricted feeding.